• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results

    Prellis Biologics' New Tool Simplifies Complex Tissue Engineering

    InspireMD's CEO Steps Down

    Celmatix Sues Research Partner 23andMe for $100M

    FDA Cleared New Cochlear Osia 2 System
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Zeus

    RJG Inc.

    Carclo Technical Plastics

    Accumold

    NN Life Sciences/Paragon Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EU's MDR: Irresistible Force Meets Immovable Object

    Ladies First: An Examination of the Women's Health Device Industry

    Localizing Medical Devices

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Lyons

    Accumold

    Glenbrook Technologies Inc.

    NN Life Sciences/Paragon Medical

    GS Plastic Optics
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    HIV Test Adapted to Develop Rapid Zika Virus Diagnostic Test

    Zika test uses saliva to detect both nucleic acids and antibodies of the virus.

    HIV Test Adapted to Develop Rapid Zika Virus Diagnostic Test
    Researchers at NYU College of Dentistry, including Maite Sabalza, Ph.D. (left) and Daniel Malamud, Ph.D. (right), are developing a test for Zika virus that uses saliva to identify diagnostic markers of the virus in a fraction of the time of current tests. Image courtesy of NYU/Sapna Parikh.
    Related CONTENT
    • ‘Brain Glue’ Repairs Traumatic Brain Injuries
    • Blood Test May Predict Lung Cancer
    • Robotic System Monitors Specific Neurons
    • New Microchip Technology Could Be Used to Track 'Smart Pills'
    • Blood Testing via Sound Waves Could Replace Some Tissue Biopsies
    New York University02.26.18
    Researchers at New York University College of Dentistry (NYU Dentistry), in collaboration with Rheonix, Inc. (Ithaca, N.Y.), are developing a novel test for Zika virus that uses saliva to identify diagnostic markers of the virus in a fraction of the time of current commercial tests.
     
    The test, which was adapted from an existing model developed by NYU and Rheonix for rapid HIV testing, is described in two new publications appearing in PLOS ONE and the Journal of Visualized Experiments (JoVE).
     
    How Zika Is Tested
    Outbreaks of infectious diseases are occurring with growing frequency thanks to factors such as population concentration and global air travel. A 2015 outbreak of Zika virus in Brazil spread to other countries in Central and South America, the Caribbean, and the Southern United States, leading the World Health Organization to declare Zika and its link to birth defects a public health emergency.
     
    “The recent Zika virus outbreak confirms that we need an effective surveillance and diagnostic program to reduce the impact of future emerging infectious diseases,” said Maite Sabalza, Ph.D., a postdoctoral associate at the Department of Basic Science and Craniofacial Biology at NYU Dentistry and the lead author of the studies in PLOS ONE and JoVE.
     
    Identifying pathogens early is critical for combatting the spread of infectious diseases. Testing often involves two separate steps: one to detect a pathogen’s nucleic acids (RNA or DNA) and another to test for antibodies, the proteins the body produces in response to pathogens.
     
    Blood samples are most often used to test for Zika virus and are typically processed using a common diagnostic technique called real-time polymerase chain reaction (RT-PCR). But blood may not be the best fluid: While the virus disappears in the blood a week or two after a person is infected, it can persist longer in saliva, semen, and urine. In addition, antibodies can remain for months or years in those bodily fluids, which is why it is essential for diagnosis to also detect antibodies after infection.
     
    Backed by funding from the National Institutes of Health, NYU Dentistry researchers are developing a rapid Zika test that combines both nucleic acid and antibody assays using saliva, given that Zika virus and antibodies persist in saliva. A saliva test is also noninvasive, cost effective, and easier to collect than blood or urine.
     
    Faster Results
    The new test also has the potential to produce results in a matter of minutes instead of hours or days. Current RT-PCR tests take around three hours and specific antibody tests can take several weeks. NYU researchers are using a different method called isothermal amplification, which can detect a virus’ nucleic acids in as little as 20 minutes, and antibody tests that can take less than an hour using Zika-specific antigens.


    With evidence showing that both the nucleic acid and antibody tests work, the researchers can combine them in the Rheonix CARD cartridge to process both diagnostic assays automatically and simultaneously. Image courtesy of NYU/Sapna Parikh.

     
    “The sooner you can identify a pathogen, the sooner steps can be taken to treat and isolate people. During an epidemic, you could test people before they get on a plane. The future of going through security at the airport may not be taking off your shoes, but instead spitting into a tube,” said study author Daniel Malamud, Ph.D., professor of basic science at NYU Dentistry.
     
    From HIV to Zika
    The research team is building on its earlier collaborative work with Rheonix developing a rapid saliva test for HIV that can detect both viral RNA and antibodies.
     
    “When we developed the HIV test, we knew we could use the same model for any infectious disease. All we need to know is the nucleic acid sequence and an antigen to identify specific antibodies,” Malamud said.
     
    In PLOS ONE, the researchers describe how they altered this model to use markers that detect Zika nucleic acid sequences instead of those for HIV. They then used a portable isothermal amplification device—which could be used for point-of-care testing—to identify Zika RNA.
     
    After showing that the test could confirm the presence of the virus using both purified Zika RNA and Zika-infected saliva, they adapted the test to the Rheonix CARD cartridge and workstation, enabling them to estimate the viral load in saliva samples. Knowing the amount of virus present is useful for understanding disease severity and immune responses, particularly among pregnant women and fetuses.
     
    The researchers also identified Zika-specific antigens—which can be used to detect the Zika specific antibodies needed for testing—using a high density peptide microarray they describe in JoVE. Because Zika can be easily confused with other viruses such as Dengue and Chikungunya, identifying Zika-specific antigens paves the way for more precise diagnostic testing.
     
    With evidence showing that both the nucleic acid and antibody tests work, the researchers can combine them in the Rheonix CARD cartridge to process both diagnostic assays automatically and simultaneously. Researchers at NYU and around the world are continuing to validate their findings in further experiments using Zika-infected saliva.
     
    “In working towards the goal of quickly making effective diagnostics available, we have developed a generic protocol that can not only be used to test for Zika virus but can be adapted for the next emerging or re-emerging infectious disease,” said Sabalza. Study author Richard Montagna, Ph.D., FACB, Rheonix’s Senior Vice President for Scientific & Clinical Affairs, added, “In addition to being able to react very quickly to any newly emerging or re-emerging infectious disease, our fully automated testing platform requires virtually no hands-on efforts and is well suited for use by individuals with minimal training.”
     
    In addition to Sabalza, Malamud, and Montagna, study authors on the PLOS ONE article include Cheryl A. Barber, Talita Castro, and William R. Abrams of NYU Dentistry and Rubina Yasmin, Beum Jun Kim, and Hui Zhu of Rheonix Inc. Barber and Abrams of NYU coauthored the JoVE article.
     
    The research was supported by the National Institute of Dental and Craniofacial Research (NIDCR) of the National Institutes of Health (R44DE024456 and 3R44DE024456-03S1). Support was also provided by a Small Business Innovation Research administrative supplement grant from NIDCR R44 DE024456 that evolved out of NIDCR grant U01 DE017855 for the development of a confirmatory point-of-care diagnostic for HIV.

    Find more information on the study in PLOS ONE and JoVE.
    Related Searches
    • point-of-care
    • health
    • diagnostic
    • innovation
    Related Knowledge Center
    • Diagnostics
    Suggested For You
    CRISPR-Based Tool Uses Paper Strips to Detect Genetic Signatures CRISPR-Based Tool Uses Paper Strips to Detect Genetic Signatures
    Viz.ai Announces Advisory Board Members, Signaling Leadership in Stroke Care Innovation Viz.ai Announces Advisory Board Members, Signaling Leadership in Stroke Care Innovation
    FDA Clears Empatica FDA Clears Empatica's Smart Watch to Monitor Seizures
    Ultrathin Needle Delivers Drugs Directly to the Brain Ultrathin Needle Delivers Drugs Directly to the Brain
    Deadline: March 2019—Don’t Get Shutout of Europe Deadline: March 2019—Don’t Get Shutout of Europe
    3D Printed Microfibers Could Speed Development of Artificially Grown Body Parts 3D Printed Microfibers Could Speed Development of Artificially Grown Body Parts
    3D Printing of Living Responsive Materials and Devices 3D Printing of Living Responsive Materials and Devices
    FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test
    Medica By the Numbers Medica By the Numbers
    Could a Saliva Test Be Next for Lupus? Could a Saliva Test Be Next for Lupus?
    Surmodics Enrolls First Patient in TRANSCEND Pivotal Clinical Trial for SurVeil Drug-Coated Balloon Surmodics Enrolls First Patient in TRANSCEND Pivotal Clinical Trial for SurVeil Drug-Coated Balloon
    Integrated Lab-on-a-Chip & Smartphone Detects Infectious Disease at POC Integrated Lab-on-a-Chip & Smartphone Detects Infectious Disease at POC
    Two Firms Awarded Seed Grants to Develop Pediatric Devices Two Firms Awarded Seed Grants to Develop Pediatric Devices
    FDA Approves First Test to Screen Zika Virus in Blood Donations FDA Approves First Test to Screen Zika Virus in Blood Donations
    New Test Rapidly Diagnoses Zika New Test Rapidly Diagnoses Zika

    Related Breaking News

    • Diagnostics
      Lens-Free Microendoscope Generates High Quality Images

      Lens-Free Microendoscope Generates High Quality Images

      It also doesn't require movement to focus on objects at different depths.
      Johns Hopkins University 12.10.19

    • Diagnostics
      NeuMoDx Molecular and Sentinel Diagnostics Partner

      NeuMoDx Molecular and Sentinel Diagnostics Partner

      Work together to develop multiple new assays for the NeuMoDx Molecular Systems.
      NeuMoDx Molecular 12.10.19

    • Diagnostics
      Companies Partner to Develop Instrument-Free Molecular Diagnostic Tests

      Companies Partner to Develop Instrument-Free Molecular Diagnostic Tests

      Collaboration facilitated by the Bill & Melinda Gates Foundation through an expansion of an existing grant.
      Business Wire 12.09.19


    • Diagnostics
      BWXT to Produce Medical Radioisotope Germanium-68 to Meet Rise in Demand

      BWXT to Produce Medical Radioisotope Germanium-68 to Meet Rise in Demand

      Company is in the process of scaling up its capacity to move into full production in 2020.
      Business Wire 12.09.19

    • Diagnostics
      FDA Clears Molecular Screening Test for Detection of Antibiotic-Resistant Bacteria

      FDA Clears Molecular Screening Test for Detection of Antibiotic-Resistant Bacteria

      BD MAX Check-Points CPO assay can identify the five most common carbapenemase genes from patients.
      BD 12.09.19

    • Diagnostics
      FDA OKs Roche

      FDA OKs Roche's Nasal Swab MRSA Test

      The cobas vivoDx MRSA test can detect the bacteria in as little as five hours.
      U.S. Food and Drug Administration 12.06.19


    • Diagnostics | Digital Health | Software & IT
      Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs

      Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs

      Aim is to help pathologists identify, quantify, and characterize cancer in tissue samples and make precise diagnoses more efficiently.
      Philips 12.05.19

    • Diagnostics | Neurological
      Eye Test for Parkinson

      Eye Test for Parkinson's Gains Breakthrough Designation

      The RightEye Vision System identifies ocular tremors that may help to detect the disease at an earlier stage.
      PR Newswire 12.05.19

    • Diagnostics | Neurological
      RSNA News: MaxQ AI Expands Partnership with GE

      RSNA News: MaxQ AI Expands Partnership with GE

      MaxQ AI’s ACCIPIO ICH and Stroke platform will be integrated into GE Healthcare’s PACS solution.
      MaxQ Al 12.04.19


    • Diagnostics | Neurological
      RSNA News: MaxQ AI to Offer Accipio Applications on Blackford Platform

      RSNA News: MaxQ AI to Offer Accipio Applications on Blackford Platform

      Represents cost savings and increased quality of care.
      MaxQ AI 12.04.19

    • Diagnostics
      Hyperfine Introduces World’s First Point-of-Care MRI System

      Hyperfine Introduces World’s First Point-of-Care MRI System

      The company's portable MRI is 20 times less costly, 35 times lower power, and 10 times lighter than the most popular current MRI machines.
      Business Wire 12.04.19

    • Diagnostics | Neurological
       RSNA News: MaxQ AI’s Software Integrated with Philips

      RSNA News: MaxQ AI’s Software Integrated with Philips' Tech

      The company’s Accipio Intracranial Hemorrhage and stroke software will be added to Philips’ CT systems
      MaxQ 12.04.19

    • Diagnostics
      RSNA News: Philips Transitions to the Circular Economy

      RSNA News: Philips Transitions to the Circular Economy

      Collecting and repurposing all the large medical systems equipment.
      Philips 12.03.19

    • Diagnostics
      RSIP Vision Introduces AI-Based Multiplex IF Image Analysis Solution

      RSIP Vision Introduces AI-Based Multiplex IF Image Analysis Solution

      Provides precise results in tissue diagnosis.
      PRNewswire 12.03.19

    • Diagnostics
      RSNA News: Philips Partners with Inspira Health

      RSNA News: Philips Partners with Inspira Health

      Aims to transform patient care for residents of southern New Jersey.
      Royal Philips 12.03.19


    Breaking News
    • 15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results
    • Prellis Biologics' New Tool Simplifies Complex Tissue Engineering
    • InspireMD's CEO Steps Down
    • Celmatix Sues Research Partner 23andMe for $100M
    • FDA Cleared New Cochlear Osia 2 System
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Beckers Group Announces Global Price Increase on Coil, Industrial Coatings
    Evonik, Wynca Celebrate Groundbreaking of New Fumed Silica Plant in Zhenjiang
    Personnel Changes in Corporate Communications, Government Relations at BASF
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results
    Prellis Biologics' New Tool Simplifies Complex Tissue Engineering
    InspireMD's CEO Steps Down
    Contract Pharma

    Latest Breaking News From Contract Pharma

    CatSci Expands Capabilities with Lab Expansion
    Smart Tags on Pills Set to Improve Supply Chain Security and Patient Adherence
    PCI Pharma Services Invests in Tredegar, UK Site
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Star of E!'s Botched Gets Line Leaping Bunny Certified
    Happi

    Latest Breaking News From Happi

    Birchbox Partners with Buzzfeed
    Coty Strengthens Its Leadership
    Jennifer Garner Joins Virtue Labs
    Ink World

    Latest Breaking News From Ink World

    Smurfit Kappa, Wings for Aid Create Disaster Relief Packaging Solution
    ePac Flexible Packaging Expands into Asia Pacific Market
    United Carton Industries Company Invests in EFI Nozomi Corrugated Printer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Mark Andy joins forces with UPM Raflatac
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Simavita Set to License Sensor Technology in EU
    NDC Appoints President
    AATC Adds Two Scholarships
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    TriMed Closes Out FDA Warning Letter
    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Releases Global Semiconductor Equipment Sales Forecast
    eMagin Corporation Announces Approximately $4.3 Million Order for Military Program
    CPI Supports Smart Food-labeling Project Set to Reduce Food Waste in 2020

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.